Skip to main content
All lobbying filings

Association for Behavioral Health and Wellness

Association for Behavioral Health and Wellness filed a Q3 report for Association for Behavioral Health and Wellness on October 19, 2026.

Lobbying for Association for Behavioral Health and Wellness

As filed: ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS for ASSOCIATION FOR BEHAVIORAL HEALTH AND WELLNESS.

All filings by Association for Behavioral Health and Wellness · Everything Association for Behavioral Health and Wellness has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Expenses
$54,762
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 9
 Lobbying activity 3

-Suicide prevention and crisis services -Behavioral Health Workforce Shortages - Mental Health and Substance Use Disorder Parity - advocating for uniformity and clearer regulations for non-quantitative treatment limitations - Telehealth Expansion Act of 2025 - ABA for Autism

-Expand access to medication-assisted treatment -Drug Enforcement Agency (DEA) - rules for prescribing controlled medications via telemedicine -Contingency Management -Modernizing Opioid Treatment Access Act (MOTAA) 2.0 (S. 4941) -H.R. 5629 - bill to nullify SAMHSA rule -Teleprescribing for controlled substances -SUD treatment facility fraud

-Telehealth, reforming barriers to access to services. Extending flexibilities and repealing the 6-month in person visit requirement. -The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act -Medicaid reform -Medicaid community engagement requirements -42 CFR Part 2 as it relates to Medicaid community engagement requirements -Coverage of Peer Support specialists' services

 Bills named in this filing 2
  • S. 4941
    Modernizing Opioid Treatment Access Act 2.0 of 2026
  • H.R. 5629
    To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of …

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem